IMAX Corp Announces Executive and Director Changes
Ticker: IMAX · Form: 8-K · Filed: 2025-07-17T00:00:00.000Z
Sentiment: neutral
Topics: executive-changes, board-of-directors, filing
TL;DR
IMAX board shakeup! New execs and directors appointed.
AI Summary
IMAX Corporation announced on July 17, 2025, changes in its executive team and board of directors. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key executives.
Why It Matters
Changes in leadership and board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational direction.
Key Numbers
- 001-35066 — SEC File Number (Identifies the specific SEC filing for IMAX Corp.)
- 98-0140269 — EIN (Employer Identification Number for IMAX Corp.)
Key Players & Entities
- IMAX Corporation (company) — Registrant
- July 17, 2025 (date) — Date of report
- 2525 Speakman Drive, Mississauga, Ontario, Canada L5K 1B1 (address) — Principal executive offices
- 902 Broadway, Floor 20, New York, New York, USA 10010 (address) — Secondary address
FAQ
What specific roles have been affected by the executive departures?
The filing indicates the departure of 'certain officers' but does not specify the exact roles in this summary.
Who are the newly elected directors?
The filing mentions the election of directors but does not list their names in the provided text.
Are there any changes to executive compensation plans?
Yes, the filing notes 'Compensatory Arrangements of Certain Officers' as an item being reported.
What is the primary business address of IMAX Corporation?
The primary business address is 2525 Speakman Drive, Mississauga, Ontario, Canada L5K 1B1.
When was this 8-K filing submitted?
This 8-K filing was submitted on July 17, 2025.
From the Filing
0000921582-25-000054.txt : 20250717 0000921582-25-000054.hdr.sgml : 20250717 20250717161907 ACCESSION NUMBER: 0000921582-25-000054 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250717 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250717 DATE AS OF CHANGE: 20250717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMAX CORP CENTRAL INDEX KEY: 0000921582 STANDARD INDUSTRIAL CLASSIFICATION: PHOTOGRAPHIC EQUIPMENT & SUPPLIES [3861] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 980140269 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35066 FILM NUMBER: 251130855 BUSINESS ADDRESS: STREET 1: 2525 SPEAKMAN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5K 1B1 BUSINESS PHONE: 9054036500 MAIL ADDRESS: STREET 1: 2525 SPEAKMAN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5K 1B1 8-K 1 imax-20250717.htm 8-K imax-20250717 0000921582 FALSE 0000921582 2025-04-23 2025-04-23 0000921582 dei:OtherAddressMember 2025-04-23 2025-04-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 July 17, 2025 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) 2525 Speakman Drive 902 Broadway , Floor 20 Mississauga , Ontario , Canada L5K 1B1 New York , New York , USA 10010 ( 905 ) 403-6457 ( 212 ) 821-0142 (Address of principal executive offices, zip code, telephone numbers) N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, no par value IMAX The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter): Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 17, 2025, IMAX Corporation (the “Company”) and Richard L. Gelfond, the Company’s Chief Executive Officer, entered into a third amendment (the “Amendment”) to Mr. Gelfond’s existing employment agreement with the Company dated November 8, 2016, previously amended effective January 1, 2020 and January 1, 2023. The Amendment, which is effective as of January 1, 2026, extends the term of the existing employment agreement to December 31, 2028. Mr. Gelfond will continue to receive an annual base salary of $1.2 million and be eligible to receive a target annual bonus